BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20719938)

  • 1. Induction of intestinal multidrug resistance-associated protein 2 by glucagon-like Peptide 2 in the rat.
    Villanueva SS; Arias A; Ruiz ML; Rigalli JP; Pellegrino JM; Vore M; Catania VA; Mottino AD
    J Pharmacol Exp Ther; 2010 Nov; 335(2):332-41. PubMed ID: 20719938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucagon-like peptide 2 on hepatic, renal, and intestinal disposition of 1-chloro-2,4-dinitrobenzene.
    Villanueva SS; Perdomo VG; Ruiz ML; Rigalli JP; Arias A; Luquita MG; Vore M; Catania VA; Mottino AD
    Drug Metab Dispos; 2012 Jul; 40(7):1252-8. PubMed ID: 22453052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide 2 prevents down-regulation of intestinal multidrug resistance-associated protein 2 and P-glycoprotein in endotoxemic rats.
    Arana MR; Tocchetti GN; Zecchinati F; Londero AS; Dominguez C; Perdomo V; Rigalli JP; Villanueva SSM; Mottino AD
    Toxicology; 2017 Sep; 390():22-31. PubMed ID: 28842383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal multidrug resistance-associated protein 2 is down-regulated in fructose-fed rats.
    Londero AS; Arana MR; Perdomo VG; Tocchetti GN; Zecchinati F; Ghanem CI; Ruiz ML; Rigalli JP; Mottino AD; García F; Villanueva SSM
    J Nutr Biochem; 2017 Feb; 40():178-186. PubMed ID: 27915161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of intestinal transport of 2,4-dinitrophenyl-S-glutathione, a multidrug resistance-associated protein 2 substrate, by bilirubin treatment in rats.
    Yokooji T; Murakami T; Ogawa K; Yumoto R; Nagai J; Takano M
    J Pharm Pharmacol; 2005 May; 57(5):579-85. PubMed ID: 15901347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of expression and activity of rat intestinal multidrug resistance-associated protein 2 by cholestatic estrogens.
    Arias A; Villanueva SS; Ruiz ML; Luquita MG; Veggi LM; Pellegrino JM; Vore M; Catania VA; Mottino AD
    Drug Metab Dispos; 2009 Jun; 37(6):1277-85. PubMed ID: 19299525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute regulation of multidrug resistance-associated protein 2 localization and activity by cAMP and estradiol-17β-D-glucuronide in rat intestine and Caco-2 cells.
    Tocchetti GN; Arias A; Arana MR; Rigalli JP; Domínguez CJ; Zecchinati F; Ruiz ML; Villanueva SSM; Mottino AD
    Arch Toxicol; 2018 Feb; 92(2):777-788. PubMed ID: 29052767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraluminal nutrients acutely strengthen rat intestinal MRP2 barrier function by a glucagon-like peptide-2-mediated mechanism.
    Tocchetti GN; Domínguez CJ; Zecchinati F; Arana MR; Rigalli JP; Ruiz ML; Villanueva SSM; Mottino AD
    Acta Physiol (Oxf); 2020 Dec; 230(4):e13514. PubMed ID: 32476256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.
    Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
    J Pharm Pharmacol; 2007 Apr; 59(4):513-20. PubMed ID: 17430634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated induction of GST and MRP2 by cAMP in Caco-2 cells: Role of protein kinase A signaling pathway and toxicological relevance.
    Arana MR; Tocchetti GN; Domizi P; Arias A; Rigalli JP; Ruiz ML; Luquita MG; Banchio C; Mottino AD; Villanueva SSM
    Toxicol Appl Pharmacol; 2015 Sep; 287(2):178-190. PubMed ID: 26049102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Mrp2 in hepatic and intestinal disposition of dinitrophenyl-S-glutathione in partially hepatectomized rats.
    Villanueva SS; Ruiz ML; Luquita MG; Sánchez Pozzi EJ; Catania VA; Mottino AD
    Toxicol Sci; 2005 Mar; 84(1):4-11. PubMed ID: 15590889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid treatment on the expression and function of multidrug resistance-associated protein 2 in rat intestine.
    Yumoto R; Hamada S; Okada K; Kato Y; Ikehata M; Nagai J; Takano M
    J Pharm Sci; 2009 Aug; 98(8):2822-31. PubMed ID: 19067394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats.
    Gotoh Y; Suzuki H; Kinoshita S; Hirohashi T; Kato Y; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):433-9. PubMed ID: 10604980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated rats.
    Villanueva SS; Ruiz ML; Soroka CJ; Cai SY; Luquita MG; Torres AM; Sánchez Pozzi EJ; Pellegrino JM; Boyer JL; Catania VA; Mottino AD
    Drug Metab Dispos; 2006 Aug; 34(8):1301-9. PubMed ID: 16679389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of multidrug resistance-associated protein 2 in acute hepatic failure rats.
    Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
    Eur J Pharmacol; 2006 Sep; 546(1-3):152-60. PubMed ID: 16899240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin 1 beta in the regulation of rat intestinal multidrug resistance-associated protein 2 under conditions of experimental endotoxemia.
    Arana MR; Dominguez CJ; Zecchinati F; Tocchetti GN; Mottino AD; Villanueva SSM
    Toxicology; 2020 Aug; 441():152527. PubMed ID: 32553669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance-associated protein 2 is negatively regulated by oxidative stress in rat intestine via a posttranslational mechanism. Impact on its membrane barrier function.
    Zecchinati F; Barranco MM; Tocchetti GN; Domínguez CJ; Arana MR; Perdomo VG; Mottino AD; García F; Villanueva SSM
    Toxicology; 2021 Aug; 460():152873. PubMed ID: 34303734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat.
    Markovic MA; Srikrishnaraj A; Tsang D; Brubaker PL
    FASEB J; 2020 May; 34(5):6628-6640. PubMed ID: 32212202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
    Yusta B; Holland D; Waschek JA; Drucker DJ
    Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.